• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    176.04 Up 0.41(0.23%) 4:00PM EDT
    |After Hours : 175.79 Down 0.25 (0.14%) 4:38PM EDT
    Add to Portfolio
    Prev Close:175.63
    Open:174.08
    Bid:N/A
    Ask:179.00 x 1300
    1y Target Est:214.38
    Beta:1.21
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:171.53 - 178.14
    52wk Range:136.37 - 203.30
    Volume:1,593,367
    Avg Vol (3m):1,279,490
    Market Cap:35.59B
    P/E (ttm):54.00
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.23%35.59B
    AMGNDown 0.04%121.84B
    BAXDown 0.18%36.91B

    Key Statistics

    Forward P/E (1 yr):24.05
    P/S (ttm):15.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.90
    Quarterly EPS Est (Mar-15) :1.32
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback